What is the Ajanta Pharma Ltd share price today?

The share price of NSE:AJANTPHARM-EQ on 01 Oct 2026 (as of 15:03:00 IST) is ₹3566.3.

What is the NSE:AJANTPHARM-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:AJANTPHARM-EQ 52 week high low range shows a high of ₹3796 and a low of ₹2379.3.

What is the Ajanta Pharma Ltd market cap?

As on 01 Oct 2026, Ajanta Pharma Ltd market cap is ₹452033000000.

What is the shareholding pattern of Ajanta Pharma Ltd Stock?

The shareholding pattern of Ajanta Pharma Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 63.48% Foreign Institutional Investors (FII): 7.68% Domestic Institutional Investors (DII): 3.7% Mutual Funds: 18.1% Retail & Others: 7.04% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Ajanta Pharma Ltd?

The Price-to-Earnings (PE) ratio of Ajanta Pharma Ltd is 39.8309, and the Price-to-Book (PB) ratio is 7.7404, as on 01 Oct 2026.

Ajanta Pharma Share Price

3328.20+0.00 (-2.09%)

+37.59% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-2.09%

1 Week

-2.40%

1 Month

-5.81%

3 Month

-3.61%

6 Month

+19.28%

YTD

+20.20%

1 Year

+37.59%

5 Year

+120.96%

10 Year

+158.45%

Max

+16177.44%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

3310.00

3301.00

2740.80

2380.19

High

3413.90

3421.40

3758.90

3796.00

About

Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages. Its business includes Branded Generics in emerging markets of Asia and Africa, Generics Read more

Pharmaceuticals & Drugs

Midcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

ZYDUSLIFENSE

LAURUSLABSNSE

CIPLANSE

DRREDDYNSE

MANKINDNSE

AUROPHARMANSE

LUPINNSE

AJANTPHARMNSE

LTP

1W Low

1W High

Market cap (₹)

1746.4-13.6 (-0.77%)

1725.50

1776.60

4,24,466Cr

9023-317 (-3.39%)

8937.50

9431.50

2,46,222Cr

4580-76.9 (-1.65%)

4551.80

4682

1,76,301Cr

1124.7+7.2 (0.64%)

1107.30

1150.90

1,12,818Cr

2036.9+0.3 (0.01%)

2007.80

2069.20

1,10,823Cr

1314.6+13.6 (1.05%)

1300.20

1333.30

1,07,447Cr

1216+19 (1.59%)

1196.90

1250.70

1,03,471Cr

2335-33.5 (-1.41%)

2317.50

2426.80

97,850Cr

1662.9-30.1 (-1.78%)

1654.10

1715

96,836Cr

1953.2-3.3 (-0.17%)

1925.70

1964.90

89,629Cr

3330-80.1 (-2.35%)

3269.90

3421.40

41,753Cr

Ajanta Pharma Share Price

3328.20+0.00 (-2.09%)

+37.59% past 1 Year

Financial overview

Compounded Sales Growth

10 years12%

5 years14%

3 years13%

Last year17%

Compounded Profit Growth

10 years10%

5 years10%

3 years22%

Last year15%

Stock Price CAGR

10 years10%

5 years17%

3 years23%

1 year38%

Return on Equity

10 years24%

5 years23%

3 years25%

Last year25%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
12%	14%	13%	17%
10%	10%	22%	15%
10%	17%	23%	38%
24%	23%	25%	25%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

ZYDUSLIFE

LAURUSLABS

CIPLA

DRREDDY

MANKIND

AUROPHARMA

LUPIN

AJANTPHARM

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,770.7	₹422067 Cr	34.89	12.07	62.82	₹11479 Cr
9,285	₹248983 Cr	85.12	34.04	128.41	₹2568 Cr
4,642.9	₹177974 Cr	81.6	16.72	97.06	₹2163 Cr
1,132.5	₹113616 Cr	25.18	9.42	62.53	₹5040 Cr
2,059.4	₹111899 Cr	102.34	6.8	29.25	₹889 Cr
1,329.6	₹106130 Cr	31.49	9.77	57.87	₹3879 Cr
1,240	₹102707 Cr	31.87	5.32	63.99	₹4196 Cr
2,372	₹99090 Cr	48.51	13.75	71.08	₹1913 Cr
1,684.6	₹97973 Cr	26.39	17.95	96.84	₹3505 Cr
1,953.6	₹88989 Cr	16.1	30.95	154.35	₹5333 Cr
3,328.2	₹42463 Cr	37.42	26.66	104.93	₹1056 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020	Jun 2020	Mar 2020	Dec 2019	Sep 2019	Jun 2019	Mar 2019	Dec 2018	Sep 2018	Jun 2018	Mar 2018	Dec 2017	Sep 2017	Jun 2017	Mar 2017	Dec 2016	Sep 2016	Jun 2016	Mar 2016	Dec 2015	Sep 2015	Jun 2015	Mar 2015	Dec 2014	Sep 2014	Jun 2014
₹1626 Cr	₹1422 Cr	₹1375 Cr	₹1354 Cr	₹1303 Cr	₹1170 Cr	₹1146 Cr	₹1187 Cr	₹1145 Cr	₹1054 Cr	₹1105 Cr	₹1028 Cr	₹1021 Cr	₹882 Cr	₹972 Cr	₹938 Cr	₹951 Cr	₹870 Cr	₹838 Cr	₹885 Cr	₹748 Cr	₹757 Cr	₹749 Cr	₹716 Cr	₹668 Cr	₹682 Cr	₹651 Cr	₹643 Cr	₹612 Cr	₹515 Cr	₹485 Cr	₹544 Cr	₹511 Cr	₹530 Cr	₹587 Cr	₹540 Cr	₹473 Cr	₹477 Cr	₹533 Cr	₹516 Cr	₹476 Cr	₹431 Cr	₹477 Cr	₹442 Cr	₹391 Cr	₹372 Cr	₹408 Cr	₹372 Cr	₹322 Cr
₹71 Cr	₹61 Cr	₹25 Cr	₹59 Cr	₹26 Cr	₹18 Cr	₹30 Cr	₹19 Cr	₹26 Cr	₹36 Cr	₹14 Cr	₹21 Cr	₹32 Cr	₹37 Cr	₹35 Cr	₹40 Cr	₹33 Cr	₹29 Cr	₹24 Cr	₹30 Cr	₹33 Cr	₹3 Cr	₹5 Cr	₹5 Cr	₹13 Cr	₹57 Cr	₹15 Cr	₹13 Cr	₹8 Cr	₹2 Cr	₹4 Cr	₹15 Cr	₹8 Cr	₹5 Cr	₹15 Cr	₹9 Cr	₹5 Cr	₹6 Cr	₹19 Cr	₹7 Cr	₹5 Cr	₹5 Cr	₹2 Cr	₹6 Cr	₹8 Cr	₹5 Cr	₹5 Cr	₹4 Cr	₹5 Cr
₹1697 Cr	₹1483 Cr	₹1400 Cr	₹1413 Cr	₹1329 Cr	₹1189 Cr	₹1177 Cr	₹1206 Cr	₹1171 Cr	₹1090 Cr	₹1119 Cr	₹1050 Cr	₹1053 Cr	₹919 Cr	₹1007 Cr	₹978 Cr	₹984 Cr	₹900 Cr	₹862 Cr	₹914 Cr	₹781 Cr	₹759 Cr	₹754 Cr	₹721 Cr	₹681 Cr	₹739 Cr	₹666 Cr	₹656 Cr	₹620 Cr	₹517 Cr	₹490 Cr	₹559 Cr	₹519 Cr	₹536 Cr	₹602 Cr	₹550 Cr	₹478 Cr	₹483 Cr	₹552 Cr	₹522 Cr	₹481 Cr	₹436 Cr	₹479 Cr	₹448 Cr	₹399 Cr	₹377 Cr	₹412 Cr	₹376 Cr	₹326 Cr
₹1247 Cr	₹1134 Cr	₹1036 Cr	₹1069 Cr	₹993 Cr	₹913 Cr	₹861 Cr	₹910 Cr	₹849 Cr	₹810 Cr	₹825 Cr	₹771 Cr	₹783 Cr	₹765 Cr	₹836 Cr	₹774 Cr	₹761 Cr	₹695 Cr	₹630 Cr	₹654 Cr	₹559 Cr	₹528 Cr	₹536 Cr	₹470 Cr	₹473 Cr	₹557 Cr	₹489 Cr	₹488 Cr	₹466 Cr	₹407 Cr	₹396 Cr	₹395 Cr	₹371 Cr	₹407 Cr	₹405 Cr	₹371 Cr	₹359 Cr	₹338 Cr	₹371 Cr	₹357 Cr	₹323 Cr	₹300 Cr	₹325 Cr	₹299 Cr	₹279 Cr	₹252 Cr	₹276 Cr	₹256 Cr	₹237 Cr
₹494 Cr	₹395 Cr	₹407 Cr	₹387 Cr	₹378 Cr	₹315 Cr	₹351 Cr	₹331 Cr	₹357 Cr	₹314 Cr	₹328 Cr	₹312 Cr	₹303 Cr	₹186 Cr	₹204 Cr	₹237 Cr	₹255 Cr	₹236 Cr	₹264 Cr	₹292 Cr	₹253 Cr	₹262 Cr	₹247 Cr	₹279 Cr	₹236 Cr	₹208 Cr	₹201 Cr	₹191 Cr	₹176 Cr	₹129 Cr	₹112 Cr	₹181 Cr	₹166 Cr	₹145 Cr	₹213 Cr	₹193 Cr	₹132 Cr	₹163 Cr	₹197 Cr	₹179 Cr	₹171 Cr	₹147 Cr	₹166 Cr	₹160 Cr	₹130 Cr	₹138 Cr	₹149 Cr	₹133 Cr	₹101 Cr
₹3 Cr	₹2 Cr	₹5 Cr	₹3 Cr	₹5 Cr	₹6 Cr	₹8 Cr	₹6 Cr	₹73 L	₹2 Cr	₹2 Cr	₹2 Cr	₹85 L	₹1 Cr	₹3 Cr	₹99 L	₹88 L	₹7 Cr	₹95 L	₹40 L	₹2 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹4 Cr	₹2 Cr	₹5 Cr	₹2 Cr	₹77 L	₹9 L	₹13 L	₹17 L	₹11 L	₹14 L	₹9 L	₹7 L	₹39 L	₹28 L	₹29 L	₹40 L	₹1 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹2 Cr
₹447 Cr	₹347 Cr	₹359 Cr	₹341 Cr	₹331 Cr	₹269 Cr	₹307 Cr	₹290 Cr	₹322 Cr	₹278 Cr	₹291 Cr	₹276 Cr	₹269 Cr	₹152 Cr	₹168 Cr	₹203 Cr	₹222 Cr	₹198 Cr	₹231 Cr	₹260 Cr	₹220 Cr	₹229 Cr	₹215 Cr	₹249 Cr	₹207 Cr	₹176 Cr	₹175 Cr	₹162 Cr	₹151 Cr	₹109 Cr	₹93 Cr	₹164 Cr	₹148 Cr	₹128 Cr	₹198 Cr	₹178 Cr	₹119 Cr	₹144 Cr	₹181 Cr	₹165 Cr	₹158 Cr	₹134 Cr	₹153 Cr	₹148 Cr	₹119 Cr	₹115 Cr	₹135 Cr	₹119 Cr	₹87 Cr
₹334 Cr	₹267 Cr	₹274 Cr	₹260 Cr	₹255 Cr	₹225 Cr	₹233 Cr	₹216 Cr	₹246 Cr	₹203 Cr	₹210 Cr	₹195 Cr	₹208 Cr	₹122 Cr	₹135 Cr	₹157 Cr	₹175 Cr	₹151 Cr	₹192 Cr	₹196 Cr	₹174 Cr	₹159 Cr	₹177 Cr	₹170 Cr	₹148 Cr	₹129 Cr	₹108 Cr	₹116 Cr	₹115 Cr	₹89 Cr	₹67 Cr	₹125 Cr	₹106 Cr	₹94 Cr	₹147 Cr	₹132 Cr	₹95 Cr	₹114 Cr	₹143 Cr	₹131 Cr	₹120 Cr	₹109 Cr	₹114 Cr	₹103 Cr	₹86 Cr	₹74 Cr	₹93 Cr	₹83 Cr	₹60 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹25 Cr	₹25 Cr	₹25 Cr	₹25 Cr	₹17 Cr	₹17 Cr	₹18 Cr	₹18 Cr	₹18 Cr	₹18 Cr	₹18 Cr	₹18 Cr	₹18 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr
₹3 Cr	₹5 Cr	₹6 Cr	₹34 L	₹30 L	₹54 L	₹47 L	₹1 Cr	₹2 Cr	₹2 Cr	₹27 L	₹43 L	₹58 L	₹50 L	₹0	₹0	₹0	₹0	₹0
₹4499 Cr	₹3760 Cr	₹3536 Cr	₹3362 Cr	₹3247 Cr	₹2978 Cr	₹2581 Cr	₹2227 Cr	₹2022 Cr	₹1548 Cr	₹1173 Cr	₹823 Cr	₹575 Cr	₹381 Cr	₹286 Cr	₹217 Cr	₹173 Cr	₹145 Cr	₹123 Cr
₹4499 Cr	₹3760 Cr	₹3536 Cr	₹3362 Cr	₹3247 Cr	₹2978 Cr	₹2581 Cr	₹2227 Cr	₹2022 Cr	₹1548 Cr	₹1173 Cr	₹823 Cr	₹575 Cr	₹381 Cr	₹286 Cr	₹217 Cr	₹173 Cr	₹145 Cr	₹123 Cr
₹4527 Cr	₹3790 Cr	₹3567 Cr	₹3388 Cr	₹3264 Cr	₹2996 Cr	₹2599 Cr	₹2245 Cr	₹2041 Cr	₹1568 Cr	₹1191 Cr	₹841 Cr	₹593 Cr	₹393 Cr	₹298 Cr	₹229 Cr	₹185 Cr	₹157 Cr	₹135 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹30 L
₹0	₹0	₹0	₹1 Cr	₹2 Cr	₹2 Cr	₹74 L	₹66 L	₹1 Cr	₹1 Cr	₹6 Cr	₹23 Cr	₹42 Cr	₹58 Cr	₹62 Cr	₹48 Cr	₹206 Cr	₹211 Cr	₹141 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹9 Cr	₹10 Cr	₹11 Cr	₹16 Cr	₹14 Cr	₹11 Cr	₹22 Cr	₹39 Cr	₹32 Cr
-₹71 Cr	-₹76 Cr	-₹26 Cr	₹95 L	₹46 Cr	₹42 Cr	₹56 Cr	₹27 Cr	₹24 Cr	₹3 Cr	₹11 Cr	₹15 Cr	₹23 Cr	₹24 Cr	₹17 Cr	₹11 Cr	₹5 Cr	₹57 L	-₹3 Cr
₹43 Cr	₹38 Cr	₹27 Cr	₹29 Cr	₹21 Cr	₹23 Cr	₹16 Cr	₹33 L	₹0	₹9 L	₹46 L	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹0	₹0	₹0
₹60 Cr	₹80 Cr	₹40 Cr	₹147 Cr	₹216 Cr	₹208 Cr	₹155 Cr	₹134 Cr	₹13 Cr	₹5 Cr	₹3 Cr	₹5 Cr	₹3 Cr	₹3 Cr	₹5 Cr	₹3 Cr	₹0	₹0	₹0
₹33 Cr	₹42 Cr	₹41 Cr	₹177 Cr	₹285 Cr	₹275 Cr	₹228 Cr	₹162 Cr	₹39 Cr	₹9 Cr	₹29 Cr	₹56 Cr	₹81 Cr	₹102 Cr	₹101 Cr	₹76 Cr	₹233 Cr	₹251 Cr	₹171 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹544 Cr	₹454 Cr	₹463 Cr	₹423 Cr	₹327 Cr	₹374 Cr	₹362 Cr	₹225 Cr	₹250 Cr	₹178 Cr	₹146 Cr	₹109 Cr	₹125 Cr	₹132 Cr	₹101 Cr	₹71 Cr	₹69 Cr	₹45 Cr	₹43 Cr
₹629 Cr	₹478 Cr	₹370 Cr	₹669 Cr	₹301 Cr	₹214 Cr	₹180 Cr	₹111 Cr	₹64 Cr	₹46 Cr	₹57 Cr	₹58 Cr	₹48 Cr	₹19 Cr	₹43 Cr	₹30 Cr	₹7 L	₹5 L	₹4 L
₹207 Cr	₹0	₹0	₹0	₹0	₹0	₹43 Cr	₹33 Cr	₹0	₹0	₹46 Cr	₹18 Cr	₹61 Cr	₹51 Cr	₹95 Cr	₹109 Cr	₹0	₹0	₹0
₹307 Cr	₹353 Cr	₹63 Cr	₹47 Cr	₹19 Cr	₹251 Cr	₹160 Cr	₹128 Cr	₹32 Cr	₹22 Cr	₹11 Cr	₹64 Cr	₹43 Cr	₹20 Cr	₹10 Cr	₹8 Cr	₹8 Cr	₹6 Cr	₹9 Cr
₹1687 Cr	₹1285 Cr	₹895 Cr	₹1139 Cr	₹647 Cr	₹839 Cr	₹746 Cr	₹498 Cr	₹346 Cr	₹247 Cr	₹260 Cr	₹250 Cr	₹275 Cr	₹222 Cr	₹250 Cr	₹218 Cr	₹77 Cr	₹51 Cr	₹51 Cr
₹6247 Cr	₹5117 Cr	₹4504 Cr	₹4705 Cr	₹4197 Cr	₹4109 Cr	₹3572 Cr	₹2906 Cr	₹2426 Cr	₹1823 Cr	₹1479 Cr	₹1146 Cr	₹949 Cr	₹718 Cr	₹649 Cr	₹522 Cr	₹495 Cr	₹459 Cr	₹357 Cr
₹8 Cr	₹8 Cr	₹4 Cr	₹4 Cr	₹7 Cr	₹82 Cr	₹49 Cr	₹46 Cr	₹10 Cr	₹12 Cr	₹18 Cr	₹5 Cr	₹2 Cr	₹3 Cr	₹73 Cr	₹52 Cr	₹17 Cr	₹33 Cr	₹16 Cr
₹212 Cr	₹3 Cr	₹1 Cr	₹1 Cr	₹2 Cr	₹2 Cr	₹46 Cr	₹36 Cr	₹2 Cr	₹1 Cr	₹81 Cr	₹72 Cr	₹130 Cr	₹125 Cr	₹200 Cr	₹191 Cr	₹228 Cr	₹250 Cr	₹174 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹3046 Cr	₹2801 Cr	₹2389 Cr	₹2283 Cr	₹2207 Cr	₹2130 Cr	₹1965 Cr	₹1579 Cr	₹1417 Cr	₹895 Cr	₹716 Cr	₹550 Cr	₹492 Cr	₹438 Cr	₹378 Cr	₹313 Cr	₹243 Cr	₹192 Cr	₹142 Cr
₹1179 Cr	₹1039 Cr	₹910 Cr	₹786 Cr	₹703 Cr	₹598 Cr	₹502 Cr	₹411 Cr	₹365 Cr	₹306 Cr	₹265 Cr	₹262 Cr	₹213 Cr	₹166 Cr	₹132 Cr	₹99 Cr	₹74 Cr	₹54 Cr	₹40 Cr
₹1867 Cr	₹1762 Cr	₹1479 Cr	₹1496 Cr	₹1504 Cr	₹1532 Cr	₹1463 Cr	₹1168 Cr	₹1053 Cr	₹589 Cr	₹451 Cr	₹288 Cr	₹279 Cr	₹273 Cr	₹246 Cr	₹214 Cr	₹168 Cr	₹138 Cr	₹102 Cr
₹258 Cr	₹176 Cr	₹256 Cr	₹209 Cr	₹153 Cr	₹108 Cr	₹132 Cr	₹262 Cr	₹61 Cr	₹253 Cr	₹198 Cr	₹155 Cr	₹88 Cr	₹12 Cr	₹3 Cr	₹17 Cr	₹47 Cr	₹55 Cr	₹24 Cr
₹29 Cr	₹25 Cr	₹19 Cr	₹25 Cr	₹25 Cr	₹0	₹12 Cr	₹13 Cr	₹8 Cr	₹0	₹0	₹40 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr
₹29 Cr	₹25 Cr	₹19 Cr	₹25 Cr	₹25 Cr	₹0	₹12 Cr	₹13 Cr	₹8 Cr	₹0	₹0	₹40 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr
₹85 Cr	₹18 Cr	₹14 Cr	₹135 Cr	₹236 Cr	₹231 Cr	₹166 Cr	₹148 Cr	₹77 Cr	₹42 Cr	₹21 Cr	₹9 Cr	₹39 Cr	₹49 Cr	₹51 Cr	₹34 Cr	₹0	₹0	₹0
₹2 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹6 Cr	₹11 Cr	₹9 Cr	₹4 Cr	₹4 Cr	₹2 Cr	₹4 Cr	₹5 Cr	₹9 Cr	₹7 Cr	₹1 Cr	₹3 Cr	₹0	₹0	₹0
₹2240 Cr	₹1985 Cr	₹1773 Cr	₹1871 Cr	₹1932 Cr	₹1891 Cr	₹1791 Cr	₹1605 Cr	₹1202 Cr	₹973 Cr	₹716 Cr	₹513 Cr	₹429 Cr	₹349 Cr	₹309 Cr	₹277 Cr	₹224 Cr	₹202 Cr	₹134 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹560 Cr	₹439 Cr	₹330 Cr	₹510 Cr	₹122 Cr	₹176 Cr	₹67 Cr	₹65 Cr	₹182 Cr	₹182 Cr	₹77 Cr	₹19 Cr	₹55 Cr	₹0	₹0	₹0	₹0	₹0	₹0
₹939 Cr	₹904 Cr	₹828 Cr	₹816 Cr	₹791 Cr	₹766 Cr	₹496 Cr	₹436 Cr	₹351 Cr	₹211 Cr	₹205 Cr	₹159 Cr	₹155 Cr	₹148 Cr	₹168 Cr	₹113 Cr	₹120 Cr	₹104 Cr	₹93 Cr
₹1854 Cr	₹1183 Cr	₹1247 Cr	₹1057 Cr	₹1020 Cr	₹738 Cr	₹775 Cr	₹459 Cr	₹460 Cr	₹323 Cr	₹372 Cr	₹259 Cr	₹202 Cr	₹150 Cr	₹141 Cr	₹104 Cr	₹97 Cr	₹100 Cr	₹87 Cr
₹105 Cr	₹176 Cr	₹131 Cr	₹331 Cr	₹212 Cr	₹210 Cr	₹205 Cr	₹101 Cr	₹93 Cr	₹70 Cr	₹43 Cr	₹137 Cr	₹60 Cr	₹46 Cr	₹11 Cr	₹12 Cr	₹15 Cr	₹8 Cr	₹6 Cr
₹53 Cr	₹39 Cr	₹54 Cr	₹22 Cr	₹35 Cr	₹52 Cr	₹55 Cr	₹97 Cr	₹115 Cr	₹9 Cr	₹3 Cr	₹12 Cr	₹3 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹0	₹0	₹0
₹497 Cr	₹378 Cr	₹132 Cr	₹89 Cr	₹85 Cr	₹276 Cr	₹183 Cr	₹143 Cr	₹23 Cr	₹56 Cr	₹64 Cr	₹47 Cr	₹44 Cr	₹21 Cr	₹16 Cr	₹14 Cr	₹40 Cr	₹45 Cr	₹37 Cr
₹4007 Cr	₹3119 Cr	₹2722 Cr	₹2825 Cr	₹2264 Cr	₹2218 Cr	₹1781 Cr	₹1301 Cr	₹1224 Cr	₹851 Cr	₹763 Cr	₹633 Cr	₹520 Cr	₹369 Cr	₹340 Cr	₹246 Cr	₹271 Cr	₹257 Cr	₹223 Cr
₹2320 Cr	₹1834 Cr	₹1827 Cr	₹1686 Cr	₹1617 Cr	₹1379 Cr	₹1036 Cr	₹802 Cr	₹878 Cr	₹604 Cr	₹503 Cr	₹384 Cr	₹245 Cr	₹147 Cr	₹89 Cr	₹28 Cr	₹194 Cr	₹206 Cr	₹172 Cr
₹6247 Cr	₹5117 Cr	₹4504 Cr	₹4705 Cr	₹4197 Cr	₹4109 Cr	₹3572 Cr	₹2906 Cr	₹2426 Cr	₹1823 Cr	₹1479 Cr	₹1146 Cr	₹949 Cr	₹718 Cr	₹649 Cr	₹522 Cr	₹495 Cr	₹459 Cr	₹357 Cr
₹362	₹303	₹283	₹269	₹382	₹346	₹298	₹257	₹232	₹178	₹135	₹96	₹169	₹168	₹254	₹195	₹158	₹134	₹115
₹362	₹303	₹283	₹269	₹255	₹231	₹199	₹171	₹155	₹119	₹90	₹64	₹45	₹30	₹23	₹17	₹14	₹12	₹10

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008
₹1378 Cr	₹1189 Cr	₹1114 Cr	₹745 Cr	₹909 Cr	₹900 Cr	₹664 Cr	₹514 Cr	₹623 Cr	₹648 Cr	₹559 Cr	₹456 Cr	₹330 Cr	₹164 Cr	₹91 Cr	₹56 Cr	₹39 Cr	₹30 Cr	₹29 Cr
₹163 Cr	₹112 Cr	₹83 Cr	₹131 Cr	₹92 Cr	₹115 Cr	₹71 Cr	₹62 Cr	₹52 Cr	₹86 Cr	₹53 Cr	₹51 Cr	₹51 Cr	₹65 Cr	₹51 Cr	₹43 Cr	₹40 Cr	₹38 Cr	₹26 Cr
-₹653 Cr	₹179 Cr	-₹100 Cr	₹67 Cr	-₹200 Cr	-₹209 Cr	-₹123 Cr	-₹83 Cr	-₹254 Cr	₹26 Cr	-₹124 Cr	-₹82 Cr	-₹75 Cr	₹39 Cr	-₹55 Cr	₹6 Cr	₹22 Cr	-₹28 Cr	-₹33 Cr
₹888 Cr	₹1480 Cr	₹1097 Cr	₹943 Cr	₹801 Cr	₹807 Cr	₹612 Cr	₹493 Cr	₹421 Cr	₹760 Cr	₹488 Cr	₹426 Cr	₹306 Cr	₹267 Cr	₹88 Cr	₹105 Cr	₹100 Cr	₹40 Cr	₹22 Cr
₹529 Cr	₹1157 Cr	₹785 Cr	₹792 Cr	₹562 Cr	₹576 Cr	₹457 Cr	₹375 Cr	₹281 Cr	₹609 Cr	₹326 Cr	₹279 Cr	₹212 Cr	₹234 Cr	₹70 Cr	₹95 Cr	₹95 Cr	₹35 Cr	₹19 Cr
-₹429 Cr	-₹377 Cr	₹65 Cr	-₹560 Cr	-₹74 Cr	-₹282 Cr	-₹224 Cr	-₹223 Cr	-₹256 Cr	-₹383 Cr	-₹209 Cr	-₹158 Cr	-₹188 Cr	-₹104 Cr	-₹53 Cr	-₹51 Cr	-₹43 Cr	-₹82 Cr	-₹59 Cr
-₹168 Cr	-₹733 Cr	-₹1051 Cr	-₹108 Cr	-₹460 Cr	-₹318 Cr	-₹129 Cr	-₹147 Cr	-₹20 L	-₹202 Cr	-₹117 Cr	-₹105 Cr	-₹20 Cr	-₹104 Cr	-₹13 Cr	-₹56 Cr	-₹46 Cr	₹50 Cr	₹38 Cr
-₹68 Cr	₹47 Cr	-₹201 Cr	₹124 Cr	₹28 Cr	-₹24 Cr	₹104 Cr	₹4 Cr	₹25 Cr	₹24 Cr	-₹25 L	₹16 Cr	₹4 Cr	₹26 Cr	₹4 Cr	-₹11 Cr	₹7 Cr	₹2 Cr	-₹2 Cr
₹175 Cr	₹129 Cr	₹330 Cr	₹206 Cr	₹178 Cr	₹202 Cr	₹95 Cr	₹91 Cr	₹66 Cr	₹41 Cr	₹42 Cr	₹39 Cr	₹34 Cr	₹8 Cr	₹4 Cr	₹15 Cr	₹8 Cr	₹6 Cr	₹7 Cr
₹107 Cr	₹177 Cr	₹129 Cr	₹331 Cr	₹205 Cr	₹178 Cr	₹199 Cr	₹95 Cr	₹91 Cr	₹66 Cr	₹41 Cr	₹54 Cr	₹39 Cr	₹34 Cr	₹8 Cr	₹4 Cr	₹15 Cr	₹8 Cr	₹6 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Ajanta Pharma Share Price

3328.20+0.00 (-2.09%)

+37.59% past 1 Year

Shareholding summary

Promoters

63.47%

FII

7.62%

DII

3.99%

17.95%

Others

6.97%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
63.47%	63.48%	66.25%	66.25%	66.25%	66.26%
7.62%	7.68%	8.26%	7.97%	8.53%	8.86%
3.99%	3.70%	3.14%	3.09%	3.23%	2.78%
17.95%	18.10%	15.22%	15.49%	14.67%	14.72%
6.97%	7.04%	7.13%	7.20%	7.32%	7.38%

Bulk & block deals

Name

Kotak Mahindra Mutual Fund

Ravi Agrawal Trust

Kotak Mahindra Mutual Fund

Aditya Birla Sun Life Mutual Fund

Ravi Agrawal Trust

Societe Generale

Marshallwaceinvestmentstrategiesmarketneutraltopsfund

Marshall Wace Investment Strategiesgtops Fund

Bnp Paribas Arbitrage

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
09 Jun 2026	Purchase	623.96 Cr	₹2,968	21.02 L	Bulk	1.682385	NSE
09 Jun 2026	Sell	1,023.96 Cr	₹2,968	34.50 L	Bulk	2.760906	NSE
09 Jun 2026	Purchase	623.96 Cr	₹2,968	21.02 L	Block	1.682385	NSE
09 Jun 2026	Purchase	400 Cr	₹2,968	13.48 L	Block	1.078521	NSE
09 Jun 2026	Sell	1,023.96 Cr	₹2,968	34.50 L	Block	2.760906	NSE
25 Jan 2024	Purchase	27.58 Cr	₹2,195.50	1.26 L	Block	0.100527	BSE
25 Jan 2024	Purchase	10.52 Cr	₹2,195.50	47.90 K	Block	0.038333	BSE
25 Jan 2024	Purchase	58.95 L	₹2,195.50	2.69 K	Block	0.002149	BSE
25 Jan 2024	Sell	27.58 Cr	₹2,195.50	1.26 L	Block	0.100527	BSE
25 Jan 2024	Sell	11.11 Cr	₹2,195.50	50.59 K	Block	0.040482	BSE

Insider trading & SAST

Client name

Aayush M Agrawal, Trustee Aayush Agrawal Trust

Ctl Trusteeship Limited

Aayush Agrawal, Trustee Aayush Agrawal Trust

Aayush M Agrawal, Trustee Aayush Agrawal Trust

Ravi P Agrawal, Trustee Ravi Agrawal Trust

Ravi Agrawal, Trustee Ravi Agrawal Trust

Aayush Agrawal, Trustee Aayush Agrawal Trust

Ravi P Agrawal, Trustee Ravi Agrawal Trust

Ravi Agrawal, Trustee Ravi Agrawal Trust

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
08 Oct 2026	Promoter	Pledge	—	—	—	4.60 L	28 Sep 2026	Creation	1,21,02,386	SAST	Reg31	—
06 Oct 2026	Promoter	Pledge	—	—	—	18.52 K	22 Sep 2026	Release	1,16,66,553	SAST	Reg31	—
30 Sep 2026	Other	Acquisition	0.37	7.41	—	4.60 L	29 Sep 2026	Acquisition of Shares - Encumbrance creation	92,53,718	SAST	29(2)	Equity Shares
22 Sep 2026	Promoter	Pledge	—	—	—	9.26 L	15 Sep 2026	Release	1,21,29,459	SAST	Reg31	—
28 Aug 2026	Promoter	Pledge	—	—	—	9.76 L	19 Aug 2026	Release	1,25,56,924	SAST	Reg31	—
25 Aug 2026	Promoter	Pledge	—	—	—	23.80 K	11 Aug 2026	Release	14,82,800	SAST	Reg31	—
25 Aug 2026	Promoter	Pledge	—	—	—	6.91 K	14 Aug 2026	Release	14,73,390	SAST	Reg31	—
07 Aug 2026	Promoter	Pledge	—	—	—	9.26 L	23 Jul 2026	Release	1,20,47,783	SAST	Reg31	—
14 Jul 2026	Promoter	Pledge	0	—	—	2.60 K	09 Jul 2026	Release	15,35,096	SAST	Reg31	—
09 Jul 2026	Promoter	Pledge	—	—	—	1.78 L	25 Jun 2026	Release	27,54,140	SAST	Reg31	—

Ajanta Pharma Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Ajanta Pharma Share Price

Ajanta Pharma Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Ajanta Pharma Share Price

Ajanta Pharma Share Price

Oscillators

Moving averages

Ajanta Pharma Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Ajanta Pharma Share Price

Corporate Actions

Company details

Ajanta Pharma Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Ajanta Pharma Share Price

News

Ajanta Pharma Q1 EBITDA rises year-on-year; margin moderates slightly

Ajanta Pharma reports Q1 revenue growth to Rs 1,630 crores

Ajanta Pharma Q1 consolidated net profit jumps sharply on strong YoY growth

Ajanta Pharma receives USFDA inspection report for Paithan facility

Ajanta Pharma informs about AGM

Ajanta Pharma trades higher on the bourses

Ajanta Pharma’s promoter sells stake worth Rs 1023.96 crore

Ajanta Pharma informs about disclosure

Ajanta Pharma informs about SAST updates

Ajanta Pharma sees Rs 400 crore NSE block trade in pre open session

Ajanta Pharma informs about disclosure

Ajanta Pharma informs about secretarial compliance report

Ajanta Pharma Forecasts 16-18% Revenue Growth for FY27, Targets 27% EBITDA Margin Amid Investments.

Jefferies Maintains Buy on Ajanta Pharma with Rs 3550 Target on Strong Q4 Growth in Africa and US.

Ajanta Pharma - Quaterly Results

Ajanta Pharma Reports Q4 Revenue Growth to Rs 1422 Crores, Up from Rs 1170 Crores YoY

Ajanta Pharma Q4 EBITDA Growth Tempered by Margin Compression

Ajanta Pharma Q4 Consolidated Net Profit Rises 20% YoY to Rs 270 Crores

Ajanta Pharma reports Profit after tax of 197.28 Crores, in the March 2026 quarter

USFDA concludes inspection at Ajanta Pharma’s Paithan manufacturing facility

Ajanta Pharma Ltd Share Price Today

Ajanta Pharma Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator